Jw Holdings (096760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.118x

Based on the latest financial reports, Jw Holdings (096760) has a cash flow conversion efficiency ratio of 0.118x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩66.90 Billion ≈ $45.34 Million USD) by net assets (₩567.12 Billion ≈ $384.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jw Holdings - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Jw Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 096760 current and long-term liabilities for a breakdown of total debt and financial obligations.

Jw Holdings Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Holdings ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Taiyen Biotech Co Ltd
TW:1737
0.028x
Dynamix Corporation III Class A Ordinary Shares
NASDAQ:DNMX
9.652x
Bergbahnen Engelberg Truebsee Titlis Bet AG
SW:TIBN
0.062x
Maritime Resources Corp.
V:MAE
0.038x
RCI Hospitality Holdings Inc
NASDAQ:RICK
0.051x
GENFIT S.A. ADR/1 EO-25
F:XUPB
N/A
X-Legend Entertainment Co Ltd
TW:4994
0.036x
Peninsula Group Ltd
TA:PEN
-0.033x

Annual Cash Flow Conversion Efficiency for Jw Holdings (2007–2024)

The table below shows the annual cash flow conversion efficiency of Jw Holdings from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see Jw Holdings market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩521.39 Billion
≈ $353.34 Million
₩97.89 Billion
≈ $66.34 Million
0.188x -41.70%
2023-12-31 ₩348.75 Billion
≈ $236.35 Million
₩112.32 Billion
≈ $76.12 Million
0.322x +2.78%
2022-12-31 ₩333.26 Billion
≈ $225.85 Million
₩104.43 Billion
≈ $70.77 Million
0.313x -12.89%
2021-12-31 ₩304.82 Billion
≈ $206.57 Million
₩109.64 Billion
≈ $74.30 Million
0.360x +10.92%
2020-12-31 ₩334.97 Billion
≈ $227.00 Million
₩108.62 Billion
≈ $73.61 Million
0.324x +15.54%
2019-12-31 ₩351.62 Billion
≈ $238.29 Million
₩98.68 Billion
≈ $66.88 Million
0.281x -42.51%
2018-12-31 ₩401.00 Billion
≈ $271.75 Million
₩195.76 Billion
≈ $132.67 Million
0.488x +1640.33%
2017-12-31 ₩374.73 Billion
≈ $253.95 Million
₩10.51 Billion
≈ $7.12 Million
0.028x +126.65%
2016-12-31 ₩277.59 Billion
≈ $188.12 Million
₩-29.21 Billion
≈ $-19.80 Million
-0.105x -18.65%
2015-12-31 ₩270.31 Billion
≈ $183.18 Million
₩-23.98 Billion
≈ $-16.25 Million
-0.089x -9.45%
2014-12-31 ₩211.94 Billion
≈ $143.63 Million
₩-17.18 Billion
≈ $-11.64 Million
-0.081x +64.60%
2013-12-31 ₩236.03 Billion
≈ $159.95 Million
₩-54.03 Billion
≈ $-36.62 Million
-0.229x -5557.31%
2012-12-31 ₩205.46 Billion
≈ $139.24 Million
₩861.85 Million
≈ $584.07K
0.004x -89.87%
2010-12-31 ₩192.45 Billion
≈ $130.42 Million
₩7.97 Billion
≈ $5.40 Million
0.041x +6.94%
2008-12-31 ₩213.99 Billion
≈ $145.02 Million
₩8.28 Billion
≈ $5.61 Million
0.039x -48.81%
2007-12-31 ₩214.73 Billion
≈ $145.52 Million
₩16.24 Billion
≈ $11.01 Million
0.076x --

About Jw Holdings

KO:096760 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$200.69 Million
₩296.14 Billion KRW
Market Cap Rank
#16520 Global
#694 in Korea
Share Price
₩4280.00
Change (1 day)
-2.28%
52-Week Range
₩3035.00 - ₩4470.00
All Time High
₩26485.64
About

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more